Results 31 to 40 of about 1,348,684 (185)
International Journal of Clinical Oncology, 2023 Cutaneous apocrine carcinoma (CAC) is a rare adnexal carcinoma. Limited data exists on the demographics and overall survival (OS) of patients with CAC; thus, there is no consensus on surgical management.
Seiji Tsuruta +9 more
semanticscholar +1 more source
Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report. [PDF]
World J Clin Cases, 2020 BACKGROUND Apocrine carcinoma of the breast is a special type of invasive ductal carcinoma of the breast that is rare in clinical practice. Neoadjuvant therapy, especially neoadjuvant targeted therapy, has rarely been reported for apocrine carcinoma of ...
Yang P +6 more
europepmc +2 more sources
Apocrine carcinoma of the breast: Review
Forum of Clinical Oncology, 2023 Apocrine carcinoma of the breast is a rare subtype of breast carcinoma, which only presents as 4% among patients with breast cancer. The percentage varies based on the diagnostic criteria used by each institution to classify apocrine carcinoma.
Yang Chieh, Wang Irene, Yen Yun
doaj +1 more source
Triple-negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple-negative breast cancers. [PDF]
J Surg Oncol, 2020 Apocrine adenocarcinoma is a rare subtype of breast cancer. We sought to compare the characteristics and survival of patients diagnosed with triple‐negative apocrine adenocarcinoma to those of patients diagnosed with triple‐negative invasive ductal ...
Arciero CA +6 more
europepmc +2 more sources
The histologic spectrum of apocrine lesions of the breast [PDF]
Archive of Oncology, 2004 New data on apocrine carcinoma of the breast, especially on its unusual pathogenesis, are the facts that justify this study. The aim of this study was to describe the morphological features in both benign apocrine lesions and invasive apocrine carcinomas
Trenkić Srbobran +5 more
doaj +1 more source
JCO Precision Oncology, 2023 Case report and literature review of targeted treatment of HER2-positive cutaneous apocrine carcinoma.
K. Nowicka-Matus +7 more
semanticscholar +1 more source
Apocrine carcinoma with marked sebocyte‐like cytological features: A report of two cases
Journal of cutaneous pathology, 2023 Apocrine carcinoma cases with sebaceous differentiation have not been reported and can be misdiagnosed as sebaceous carcinoma. We present two cases of apocrine carcinoma with marked sebocyte‐like cytological features.
N. Sasaki-Saito +6 more
semanticscholar +1 more source
Archives of Medicine and Health Sciences, 2020 Apocrine Carcinoma (APC) is a rare and distinct entity among all the histological variants of invasive ductal carcinoma(IDC) of breast. It is common to encounter focal apocrine differentiation, but only 4% of IDCs show extensive apocrine differentiation.
Pranita Mohanty +3 more
doaj +1 more source
Apocrine carcinoma of the breast. Clinical, histological and immunohistochemical features
Archives of the Balkan Medical Union, 2020 Introduction. Invasive apocrine carcinoma of the breast is a rare special subtype of mammary carcinoma and accounts for 0.3-1% of all breast malignancies. It has specific histological, immunohistochemical, and molecular genetic characteristics.
Tatyana M. BETOVA +4 more
doaj +1 more source
Multiple rare neoplasms arising from the nevus sebaceous of the scalp: A case report
Gülhane Tıp Dergisi, 2022 Nevus sebaceous of Jadassohn (NSJ) is a cutaneous hamartoma of pilosebaceous origin that differentiates into multiple neoplasms, most commonly trichoblastoma/basal cell carcinoma and syringocystadenoma papilliferum (SCAP). Malignant transformation of NSJ
Deepthi Shetty +5 more
doaj +1 more source